Huntsman Cancer Institute Multiple Myeloma Clinical Trials
Huntsman Cancer Institute Multiple Myeloma Clinical Trials image
Mar 03, 2021 / 11:00AM - 12:30PM MST
Mountain West Myeloma Chapter

Event Description

Join multiple myeloma specialist, Dr. Douglas Sborov, as he reviews the open clinical trials for myeloma patients at the renowned Huntsman Institute in Salt Lake City, Utah. Clinical trials are a way to access leading-edge myeloma treatments. Myeloma patients should always consider clinical trials as one of their treatment options.

Schedule & Agenda

person
Introductions
11:00AM
Jennifer Ahlstrom
Jennifer Ahlstrom, the founder of the Myeloma Crowd, introduces the meeting agenda and our featured speaker, Dr. Douglas Sborov.
person
Presentation
11:05AM
Dr. Douglas Sborov
Dr. Sborov reviews the open clinical trials at the Hunstman Cancer Institute in SLC.
person
Questions and Answers
12:00PM
Audience
The audience asks questions about open clinical trials and other pertinent questions.

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

Read Bio
The panelist Dr. Douglas Sborov
Dr. Douglas Sborov

Dr. Douglas Sborov is an Assistant Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through the American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships and joining the Division of Hematology as a Clinical Instructor, he and his family were drawn back to the beauty of the Wasatch Front where he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program, an Associate Member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), and an active member of the HCI Protocol Review and Monitoring Committee.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811